Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 06, 2026 12:00 ET | Source: Novartis Pharma AG

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including Cambridge, Massachusetts, and Basel,...
February 06, 2026 12:00 ET | Source: Novartis Pharma AG

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including Cambridge, Massachusetts, and Basel,...
February 03, 2026 07:44 ET | Source: Research and Markets

Cell-Based Assay & High Content Screening Research Report 2026: Market Forecasts 2025-2029 - Expanding Candidate Pipelines, Immuno-Oncology Focus, and Technology Convergence Bolster Growth

Dublin, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The "Cell-Based Assay & High Content Screening Market 2025-2029 - Forecasts by User and Product, with Executive and Consultant Guides" report has been...
January 28, 2026 10:30 ET | Source: Steadman Philippon Research Institute

Steadman Philippon Research Institute and Vail Health Renew Landmark Partnership with 5-Year Commitment

Vail, Colorado, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Steadman Philippon Research Institute (SPRI) and Vail Health have renewed their longstanding partnership with a new five-year agreement advancing...
January 27, 2026 09:00 ET | Source: Muscular Dystrophy Association

Organizations Join Forces to Map How Human Muscle Regenerates

New York, Jan. 27, 2026 (GLOBE NEWSWIRE) -- A pivotal scientific collaboration born out of the Muscular Dystrophy Association’s (MDA) Muscle Regeneration Summit is advancing a first-of-its-kind...
December 08, 2025 09:00 ET | Source: Muscular Dystrophy Association

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scientific Conference

New York, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today that John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), will...
November 28, 2025 04:11 ET | Source: Research and Markets

North America Mass Spectrometry Market Report 2025-2033, Profiles of Agilent Technologies, Bruker, Danaher, Hitachi, JEOL, LECO, PerkinElmer, and Thermo Fisher Scientific

Dublin, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The "North America Mass Spectrometry Market Report by Product, Technology, End Use, Application, Countries and Company Analysis, 2025-2033" report has been...
November 24, 2025 17:16 ET | Source: Novartis Pharma AG

Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)

Ad hoc announcement pursuant to Art. 53 LR Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III...
October 30, 2025 12:06 ET | Source: Research and Markets

Cell-Based Assay & High Content Screening Market Forecast 2025-2029: New Technologies Expand Applications of Cell-Based Assays in Research

Dublin, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The "Cell-Based Assay & High Content Screening Market 2025-2029 - Forecasts by User and Product, with Executive and Consultant Guides" has been added to...
October 28, 2025 09:00 ET | Source: MRIGlobal

MRIGlobal Achieves Perfect Score in U.S. Government Cybersecurity Certification

Kansas City, MO., Oct. 28, 2025 (GLOBE NEWSWIRE) -- MRIGlobal is proud to announce that following an independent and rigorous C3PAO assessment, its Arcus CUI (Controlled Unclassified Information)...